The outlook for Viking Therapeutics in 2027 indicates a possible uptrend, with an expected price of $ 97.04 . This represents a 99.73% increase from the current ... |
18 сент. 2024 г. · Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 · 1. Moderna · 2. Vertex Pharmaceuticals · 3. Viking Therapeutics. |
26 авг. 2024 г. · Viking Therapeutics and CRISPR Therapeutics could be the best-performing biotechs through 2030, but they could also move in the opposite ... |
11 сент. 2024 г. · Over time, the analysts forecast that Viking's anticipated oral weight-loss drug could claim about 10% of the market after its projected 2030 ... |
Viking Therapeutics Inc Stock (VKTX) is expected to reach an average price of $241.47 in 2030, with a high forecast of $335.31 and a low forecast of $147.63. |
13 апр. 2024 г. · Viking Therapeutics is targeting two markets that could top $100 billion by 2030. Motley Fool Issues Rare “All In” Buy Alert · NASDAQ: CRSP. |
According to the latest long-term forecast, Viking Therapeutics price will hit $55 by the end of 2024 and then $75 by the end of 2025. Viking Therapeutics will ... |
The average one-year price target for Viking Therapeutics, Inc. is $115.82. The forecasts range from a low of $90.90 to a high of $144.90. A stock's price ... |
28 июн. 2024 г. · Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 · 1. Vertex Pharmaceuticals · 2. Viking Therapeutics · 3. TransMedics ... |
21 окт. 2024 г. · Viking Therapeutics VKTX is set to report third-quarter earnings on Oct. 23, after market close. Since the company lacks a marketed drug in ... |
Novbeti > |
Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |